Oliver Harzer
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Biochemistry top 10%
- Biochemical Acid Research Studies
Papers in
-
- SARS-CoV-2 detection and testing 4
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 3
-
- Advanced Glycation End Products research 4
- Co-authors
- Andreas Pfützner (4 shared papers)R. Renner (1 shared paper)Michael Trautmann (1 shared paper)Solomon S. Steiner (1 shared paper)L Heinemann (1 shared paper)Klaus Rave (1 shared paper)Blair Wilson (1 shared paper)T. Kunt (7 shared papers)
- Journals
- Experimental and Clinical Endocrinology & Diabetes (4 papers)Clinical Science (2 papers)PLoS ONE (2 papers)Frontiers in Medicine (2 papers)Clinical Microbiology and Infection (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Oliver Harzer
17 papers receiving 516 citations
Peers
Comparison fields: 5 of 77
- Endocrinology, Diabetes and Metabolism 188
- Biochemistry 45
- Clinical Biochemistry 39
- Orthopedics and Sports Medicine 42
- Rehabilitation 29
Countries citing papers authored by Oliver Harzer
This map shows the geographic impact of Oliver Harzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Harzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Harzer more than expected).
Fields of papers citing papers by Oliver Harzer
This network shows the impact of papers produced by Oliver Harzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Harzer. The network helps show where Oliver Harzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Oliver Harzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 139 | |
| 2 | 2002 | 89 | |
| 3 | 2020 | 81 | |
| 4 | 1999 | 70 | |
| 5 | 2000 | 34 | |
| 6 | 1999 | 23 | |
| 7 | 2020 | 20 | |
| 8 | 2020 | 16 | |
| 9 | 2009 | 16 | |
| 10 | 2009 | 13 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 7 | |
| 13 | 2007 | 6 | |
| 14 | 2021 | 6 | |
| 15 | 2022 | 3 | |
| 16 | 1998 | 3 | |
| 17 | Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus. | 2000 | 2 |
| 18 | 2022 | 0 |
About Oliver Harzer
Oliver Harzer is a scholar working on Infectious Diseases, Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Surgery and Genetics, having authored 18 papers that have together received 540 indexed citations. Recurring topics across this work include SARS-CoV-2 detection and testing (4 papers), Advanced Glycation End Products research (4 papers), Diabetes Management and Research (3 papers), COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Diabetes and associated disorders (2 papers), Biochemical Acid Research Studies (2 papers) and Eicosanoids and Hypertension Pharmacology (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (188 citations), Biochemistry (45 citations), Clinical Biochemistry (39 citations), Orthopedics and Sports Medicine (42 citations) and Rehabilitation (29 citations). Oliver Harzer has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Andreas Pfützner, R. Renner, Michael Trautmann, Solomon S. Steiner, L Heinemann, Klaus Rave, Blair Wilson, T. Kunt, M. Engelbach and Thomas Först. Their work appears in journals such as Experimental and Clinical Endocrinology & Diabetes, Clinical Science, PLoS ONE, Frontiers in Medicine and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.